FATE is currently covered by 3 analysts with an average price target of $6.25. This is a potential upside of $5.23 (512.75%) from yesterday's end of day stock price of $1.02.
Fate Therapeutics's activity chart (see below) currently has 257 price targets and 232 ratings on display. The stock rating distribution of FATE is 60% BUY and 40% HOLD.
Analysts' price targets on this stock were met 52.63% of the time, taking 125.63 days on average.
Highest price target for FATE is $8, Lowest price target is $3, average price target is $6.25.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 06-Nov-2026.
Currently out of the existing stock ratings of FATE, 3 are a BUY (60%), 2 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Mar-2023
$3
$1.72 (134.38%)
$3.5
12 days ago
(06-Nov-2026)
2/5 (40%)
$1.16 (63.04%)
49
Buy Since 14-Aug-2024
$8
$6.72 (525.00%)
$6
3 months 4 days ago
(14-Aug-2026)
19/26 (73.08%)
$5.43 (211.28%)
264
Buy Since 04-May-2026
$7
$5.72 (446.88%)
$7
5 months 10 days ago
(08-Jun-2026)
0/6 (0%)
$5.09 (266.49%)
Hold Since 27-Feb-2024
$7
$5
1 years 22 days ago
(27-Oct-2025)
12/17 (70.59%)
$5.45 (351.61%)
133
Buy Since 12-Mar-2020
$7
$10
1 years 2 months 15 days ago
(03-Sep-2025)
1/5 (20%)
$6 (600.00%)
36
What is FATE (Fate Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on FATE (Fate Therapeutics)?
Which analyst has the most public recommendations on FATE (Fate Therapeutics)?
Which analyst is the currently most bullish on FATE (Fate Therapeutics)?
Which analyst is the currently most reserved on FATE (Fate Therapeutics)?